Results of Tabula Rasa HealthCare’s First Simulated Clinical Study on Proposed COVID-19 Treatments and Therapies is Published
12 août 2020 11h02 HE
|
Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces TRHC’s...
Regence and TRHC partner on COVID-19 virtual clinical trial to assess proposed treatment risks
09 juin 2020 08h00 HE
|
Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., June 09, 2020 (GLOBE NEWSWIRE) -- Regence and Tabula Rasa HealthCare® (NASDAQ: TRHC) announced today that the companies have partnered on a virtual clinical trial to assess the...
TRHC Fills the Information Gap on COVID-19 Proposed Therapies with a New Digital Resource
19 mai 2020 08h00 HE
|
Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., May 19, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare® Corporation (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today published on...
TRHC Launches First Large Simulation Study to Assess Adverse Drug Events with proposed COVID-19 Treatments
29 avr. 2020 07h55 HE
|
Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., April 29, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare Corporation® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today...